ROTE WILLIAM E. Insider Trades

Insider Trading History

Track insider trading activity for ROTE WILLIAM E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $8.59M 145,943 shares
Last Trade
Sep 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.15M 112,850 shares
$63.33
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $0 0 shares
Last Trade
Sep 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.16M 112,850 shares
$63.48
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $12.4M 211,047 shares
Last Trade
Sep 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.16M 112,850 shares
$63.48
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $11.4M 194,395 shares
Last Trade
Sep 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.92M 78,650 shares
$62.51
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $20.6k 350 shares
Last Trade
Sep 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.92M 78,650 shares
$62.51
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $7.68M 130,488 shares
Last Trade
Sep 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.99M 96,198 shares
$62.26
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $6.8M 115,474 shares
Last Trade
May 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$121k 2,763 shares
$43.95
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $500k 8,500 shares
Last Trade
May 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 8,500 shares
$44.91
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $250k 4,250 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 4,250 shares
$44.91
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $6.96M 118,237 shares
Last Trade
May 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 4,250 shares
$44.91
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $6.71M 113,987 shares
Last Trade
Apr 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$356k 9,100 shares
$39.09
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $7.25M 123,087 shares
Last Trade
Apr 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 14,000 shares
$30.70
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $6.42M 109,087 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$409k 12,446 shares
$32.87
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $3.15M 53,570 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 53,570 shares
$33.10
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $7.16M 121,533 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$625k 20,090 shares
$31.09
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.97M 101,443 shares
Last Trade
Dec 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.41M 60,000 shares
$40.10
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $0 0 shares
Last Trade
Dec 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.42M 60,000 shares
$40.28
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $9.51M 161,443 shares
Last Trade
Dec 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.42M 60,000 shares
$40.28
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $5.9M 100,241 shares
Last Trade
May 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.3k 3,198 shares
$21.05
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Chief Research Officer
Holding Value $6.09M 103,439 shares
Last Trade
May 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 4,920 shares
$21.15
$58.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up